| Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach Y Kimura, Y Nakai, J Shin, M Hara, Y Takeda, S Kubo, SS Jeremiah, Y Ino, ... Scientific reports 11 (1), 20638, 2021 | 59 | 2021 |
| Whole nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 may cause false-positive results in serological assays Y Yamaoka, SS Jeremiah, K Miyakawa, R Saji, M Nishii, I Takeuchi, ... Clinical Infectious Diseases 72 (7), 1291-1292, 2021 | 33 | 2021 |
| Serum cholinesterase associated with COVID-19 pneumonia severity and mortality K Nakajima, T Abe, R Saji, F Ogawa, H Taniguchi, K Yamaguchi, K Sakai, ... Journal of Infection 82 (2), 282-327, 2021 | 32 | 2021 |
| Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles K Miyakawa, SS Jeremiah, N Ohtake, S Matsunaga, Y Yamaoka, M Nishi, ... Journal of Molecular Cell Biology 12 (12), 987-990, 2020 | 32 | 2020 |
| Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19 F Ogawa, Y Oi, K Nakajima, R Matsumura, T Nakagawa, T Miyagawa, ... Thrombosis journal 19, 1-9, 2021 | 26 | 2021 |
| Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays Y Yamaoka, SS Jeremiah, K Miyakawa, R Saji, M Nishii, I Takeuchi, ... Clin Infect Dis 72, 1291-2, 2020 | 26 | 2020 |
| Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19 R Saji, M Nishii, K Sakai, K Miyakawa, Y Yamaoka, T Ban, T Abe, ... PloS one 16 (8), e0256022, 2021 | 18 | 2021 |
| Prostaglandin-E2 receptor-4 stimulant rescues cardiac malfunction during myocarditis and protects the heart from adverse ventricular remodeling after myocarditis A Takakuma, M Nishii, A Valaperti, H Hiraga, R Saji, K Sakai, ... Scientific Reports 11 (1), 20961, 2021 | 7 | 2021 |
